RN7SL411P

Across TCGA pan-cancer cohorts, RN7SL411P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL411P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RN7SL411P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL411P expression acts as an unfavorable survival marker, although some lineages such as UCS and OV show a favorable association.

CESC, UCS, and OV are the cancer types where RN7SL411P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	III,IV	0.344	0.740	<.001	36	view →
UCS	DFS	Tertile	III,IV	0.672	0.172	.016	30	view →
OV	OS	Median	III,IV	0.372	0.268	.003	28	view →
UVM	DFS	Tertile	III,IV	0.129	0.673	.017	9	view →
READ	DFS	Tertile	IV	0.514	0.657	.048	9	view →
LGG	OS	Tertile	All	0.906	0.788	.018	8	view →
THCA	OS	Quartile	All	0.949	0.991	.014	8	view →
SKCM	DFS	Tertile	IV	0.805	0.111	.024	6	view →
LAML	DFS	Tertile	All	0.333	0.598	.038	6	view →
STAD	DFS	Median	III,IV	0.563	0.406	.010	5	view →
BLCA	DFS	Median	IV	0.652	0.363	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL411P–CESC (OS)

Open the CESC breakdown →